GlaxoSmithKline (GSK) has agreed to $40 million to settle a long-running lawsuit over Paxil, its beleagured antidepressent. The settlement will go to insurers to reimburse health plans that covered the use of the drug in children and adolescents.
In an earlier Paxil class action suit the drug maker paid $64 million to consumers regarding its off-label use in children and teenagers.
